_{More than 500 people could learn more about the product}

Prati-Donaduzzi Pharmaceutical Industry participated from November 17 to 20 of the 17th Brazilian Week of the Digestive System - SBAD, which took place at the Transamérica Expo Center in São Paulo. The event is considered the largest in the area of ​​Gastroenterology in Latin America.

The company sponsored a satellite symposium on the topic 'lactose intolerance and new existing technologies for treatment' by Dr. Paulo Carvalho and Dr. Nayara Salgado Carvalho. The moment also served so that the present physicians could know Sensilatte, which is the product that the industry produces for lactose intolerance.

Sensilatte aids in the digestion of lactose present in food. The tablets have patented orodispersible technology that dissolves in the mouth without the need for water ingestion. The product counts on the options: unflavored and vanilla. In addition, the fractionated blister allows the patient to stand out and take with him/her the required amount.

Prati-Donaduzzi's Marketing Manager, Lucas Angnes, highlights the benefits of attending the event. "The congress was very important for us, as it allowed the disclosure of Sensilatte to prescribers of the product. In addition, it marked the beginning of our work with the physicians. 

About Prati-Donaduzzi

Prati-Donaduzzi, the pharmaceutical industry specializing in the development and production of generic and similar drugs, is the first in the country to market fractional drugs. Based in Toledo, western Paraná, Prati-Donaduzzi has more than 4,500 employees and has one of the largest portfolios of generic drugs in Brazil. It produces, on average, 12 billion therapeutic doses per year.